Table 2

COPD medications in the year after COPD diagnosis in patients categorised by baseline LRTI frequency and severity

Overall
N=2 15 234
None n=1 58 0741 mild n=18 081≥2 mild n=61331 moderate n=19 787≥2 moderate n=6227≥1 severe
6932
Any COPD medications148 655 (69.1)106 778 (67.6)12 583 (69.6)4467 (72.8)15 403 (77.8)5109 (82.1)2617 (37.8)
Maintenance inhaled therapies
 Any COPD maintenance medications125 540 (58.3)89 637 (56.7)10 690 (59.1)3832 (62.5)13 022 (65.8)4485 (72.0)3874 (55.9)
 No COPD maintenance medications89 694 (41.7)68 437 (43.3)7391 (40.9)2301 (37.5)6765 (34.2)1742 (28.0)3058 (44.1)
 LABA monotherapy4096 (1.9)3062 (1.9)285 (1.6)93 (1.5)446 (2.3)146 (2.3)64 (0.9)
 LAMA monotherapy20 328 (9.4)14 896 (9.4)1912 (10.6)604 (9.9)1802 (9.1)497 (8.0)617 (8.9)
 ICS monotherapy14 243 (6.6)10 783 (6.8)943 (5.2)264 (4.3)1563 (7.9)491 (7.9)199 (2.9)
 LABA/ICS dual therapy38 284 (17.8)27 590 (17.5)1073 (5.9)1055 (17.2)4214 (21.3)1549 (24.9)947 (13.7)
 LABA/LAMA dual therapy8837 (4.1)6476 (4.1)1073 (5.9)388 (6.3)438 (2.2)104 (1.7)358 (5.2)
 LAMA/ICS dual therapy3137 (1.5)2234 (1.4)242 (1.3)89 (1.5)360 (1.8)131 (2.1)81 (1.2)
 Triple therapy36 615 (17.0)24 596 (15.6)3306 (18.3)1339 (21.8)4199 (21.2)1567 (25.2)1608 (23.2)
Short-acting therapies
SABA114 354 (90.1)81 630 (90.2)10 029 (93.1)3606 (93.3)11 806 (87.5)3942 (86.4)3341 (91.6)
SAMA2448 (1.9)1770 (2.0)157 (1.5)55 (1.4)320 (2.4)107 (2.3)39 (1.1)
SAMA/SABA10 060 (7.9)7122 (7.9)583 (5.4)206 (5.3)1368 (10.1)514 (11.3)267 (7.3)
  • Any COPD medications includes any maintenance COPD medications or any short-acting therapies. COPD maintenance therapies include any combination of LABA, LAMA, ICS. Triple therapy=LABA/LAMA/ICS. Short-acting therapies include SABA, SAMA. Numbers are n(%).

  • COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroids; LABA, long-acting beta agonist; LAMA, long-acting muscarinic antagonist; LRTI, lower respiratory tract infection; SABA, short-acting beta agonists; SAMA, short-acting muscarinic antagonists.